131 related articles for article (PubMed ID: 38129266)
1. Response to comment on "Definite chemoradiotherapy for early-stagebulky cervical cancer".
Hsieh HY; Lu CH; Wang L
J Formos Med Assoc; 2024 Mar; 123(3):418-419. PubMed ID: 38129266
[No Abstract] [Full Text] [Related]
2. Comment on "Definite chemoradiotherapy for early-stage bulky cervical cancer".
Zhang W; Ruan Y; Ye L; Liu M
J Formos Med Assoc; 2024 Mar; 123(3):416-417. PubMed ID: 37291045
[No Abstract] [Full Text] [Related]
3. Sequential Chemoradiotherapy vs Concurrent Chemoradiotherapy or Radiotherapy Alone in Adjuvant Treatment for Patients With Cervical Cancer.
Sari SY; Kahvecioglu A; Yildiz F
JAMA Oncol; 2021 Sep; 7(9):1404. PubMed ID: 34264280
[No Abstract] [Full Text] [Related]
4. Sequential Chemoradiotherapy vs Concurrent Chemoradiotherapy or Radiotherapy Alone in Adjuvant Treatment for Patients With Cervical Cancer-Reply.
Huang H; Feng YL; Liu JH
JAMA Oncol; 2021 Sep; 7(9):1404-1405. PubMed ID: 34264307
[No Abstract] [Full Text] [Related]
5. Monitoring treatment response in patients undergoing chemoradiotherapy for locally advanced uterine cervical cancer by additional diffusion-weighted imaging: A systematic review.
Schreuder SM; Lensing R; Stoker J; Bipat S
J Magn Reson Imaging; 2015 Sep; 42(3):572-94. PubMed ID: 25346470
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage "bulky" cervical cancer and survival impact of histological subtype.
Hsieh HY; Lu CH; Wang L
J Formos Med Assoc; 2023 Mar; 122(3):221-229. PubMed ID: 36379808
[TBL] [Abstract][Full Text] [Related]
7. Predicting Early Response to Chemoradiotherapy for Uterine Cervical Cancer Using Intravoxel Incoherent Motion MR Imaging.
Kato H; Esaki K; Yamaguchi T; Tanaka H; Kajita K; Furui T; Morishige KI; Goshima S; Matsuo M
Magn Reson Med Sci; 2019 Oct; 18(4):293-298. PubMed ID: 30787252
[TBL] [Abstract][Full Text] [Related]
8. Introduction: Cervical Cancer.
Klopp AH
Semin Radiat Oncol; 2020 Oct; 30(4):263-264. PubMed ID: 32828381
[No Abstract] [Full Text] [Related]
9. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
[TBL] [Abstract][Full Text] [Related]
10. [Chemoradiotherapy for locally advanced cervical cancer].
Bazaeva IIa; Gorbunova VA; Kravets OA; Khokhlova SV; Limareva SV; Panov VO; Strel'tsova ON; Tarachkova EV
Vopr Onkol; 2014; 60(3):280-7. PubMed ID: 25033678
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment results of external radiotherapy without brachytherapy in advanced uterine cervical cancer.
Gong SJ; Shim SJ
J Cancer Res Ther; 2021; 17(1):255-257. PubMed ID: 33723164
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
Furusawa A; Takekuma M; Mori K; Usami T; Kondo E; Nishio S; Nishino K; Miyamoto Y; Yoshimura R; Watanabe M; Mikami M; Enomoto T
Int J Gynecol Cancer; 2021 Apr; 31(4):623-626. PubMed ID: 33664127
[TBL] [Abstract][Full Text] [Related]
13. SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004.
Haie-Meder C; Fervers B; Fondrinier E; Haugh M; Lhomme C; Guastalla JP
Ann Oncol; 2005 Jul; 16(7):1100-8. PubMed ID: 15851407
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study of genes related to concomitant chemoradiotherapy resistance in advanced uterine cervical squamous cell carcinoma.
An JS; Huang MN; Song YM; Li N; Wu LY; Zhan QM
Chin Med J (Engl); 2013 Nov; 126(21):4109-15. PubMed ID: 24229683
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
Hirata K; Kodaira T; Tomita N; Ohshima Y; Ito J; Tachibana H; Nakanishi T; Fuwa N
Jpn J Clin Oncol; 2014 Jun; 44(6):556-63. PubMed ID: 24755546
[TBL] [Abstract][Full Text] [Related]
19. Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone.
Ohara K; Tanaka YO; Tsunoda H; Oki A; Satoh T; Onishi K; Kagei K; Sugahara S; Hata M; Igaki H; Tokuuye K; Akine Y; Yoshikawa H
Radiat Med; 2005 Feb; 23(1):25-9. PubMed ID: 15786748
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy for cervical cancer: what next?
Eifel PJ
J Clin Oncol; 2005 Nov; 23(33):8277-9. PubMed ID: 16230671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
